Related Experiment Video

Updated: Jan 27, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.8K

Targeting FER Kinase Inhibits Melanoma Growth and Metastasis

Iordanka A Ivanova1,2,3, Shinthujah Arulanantham4,5,6, Kevin Barr7

  • 1Department of Physiology and Pharmacology, University of Western Ontario, London, ON N6A 5C1, Canada. iivanov3@uwo.ca.

Cancers
|March 27, 2019
PubMed

Insights

Fes-related (FER) kinase promotes melanoma metastasis by regulating Wnt/β-catenin signaling and L1-CAM. Inhibiting FER kinase reduced tumor growth and distant metastases in preclinical models, suggesting FER as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Melanoma is an aggressive skin cancer with high metastatic potential.
  • Fes-related (FER) kinase, a non-receptor tyrosine kinase, is involved in epithelial tumor growth and metastasis.

Purpose of the Study:

  • To investigate the molecular role of FER kinase in melanoma metastasis.
  • To identify potential therapeutic targets for melanoma treatment.

Main Methods:

  • Depletion of FER kinase in melanoma cells.
  • Analysis of Wnt/β-catenin pathway activity and proteomic changes, including L1-cell adhesion molecule (L1-CAM) abundance.
  • Evaluation of melanoma growth and metastasis in a xenograft model.

Main Results:

  • FER depletion impaired Wnt/β-catenin pathway activity and reduced L1-CAM levels.
  • Reduced FER kinase activity decreased melanoma cell growth and the formation of distant metastases in vivo.
  • FER kinase was identified as a positive regulator of melanoma metastasis.

Conclusions:

  • FER kinase plays a critical role in melanoma progression and metastasis.
  • Targeting FER kinase may offer a novel therapeutic strategy for melanoma.
Keywords:
FERmetastasistumor invasiontyrosine kinase

More Related Videos

A Melanoma Patient-Derived Xenograft Model07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.2K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.8K

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.0K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.4K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.0K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
18.4K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.9K